Everett Harris & Co. CA acquired a new position in Utah Medical Products, Inc. (NASDAQ:UTMD) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,895 shares of the medical instruments supplier’s stock, valued at approximately $210,000. Everett Harris & Co. CA owned about 0.08% of Utah Medical Products at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Strs Ohio increased its position in shares of Utah Medical Products by 8.0% in the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after buying an additional 200 shares during the period. Rice Hall James & Associates LLC increased its position in shares of Utah Medical Products by 1.1% in the second quarter. Rice Hall James & Associates LLC now owns 3,829 shares of the medical instruments supplier’s stock worth $277,000 after buying an additional 40 shares during the period. Janney Montgomery Scott LLC increased its position in shares of Utah Medical Products by 9.3% in the second quarter. Janney Montgomery Scott LLC now owns 3,947 shares of the medical instruments supplier’s stock worth $286,000 after buying an additional 335 shares during the period. Spark Investment Management LLC acquired a new position in shares of Utah Medical Products during the second quarter worth about $325,000. Finally, Bessemer Group Inc. increased its position in shares of Utah Medical Products by 39.4% in the second quarter. Bessemer Group Inc. now owns 4,600 shares of the medical instruments supplier’s stock worth $333,000 after buying an additional 1,300 shares during the period. 65.24% of the stock is owned by institutional investors and hedge funds.
Utah Medical Products, Inc. (UTMD) opened at 72.50 on Friday. Utah Medical Products, Inc. has a one year low of $56.30 and a one year high of $75.00. The company has a 50-day moving average price of $71.33 and a 200-day moving average price of $65.77. The firm has a market capitalization of $269.63 million, a P/E ratio of 20.79 and a beta of 0.74.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 3rd. Stockholders of record on Friday, September 15th will be given a $0.265 dividend. The ex-dividend date is Thursday, September 14th. This represents a $1.06 annualized dividend and a dividend yield of 1.46%. Utah Medical Products’s payout ratio is 30.37%.
UTMD has been the subject of a number of research analyst reports. ValuEngine raised Utah Medical Products from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th. BidaskClub downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
